2017
DOI: 10.1016/j.eimc.2016.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial susceptibility of 6 antimicrobial agents in Helicobacter pylori clinical isolates by using EUCAST breakpoints compared with previously used breakpoints

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 19 publications
(18 reference statements)
0
12
0
1
Order By: Relevance
“…Interestingly, the duality of resistance rates was observed in this article for amoxicillin due to discordant cutoff proposed by the literature for Latin America [45] and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) [47]. This difference demonstrated the lack of clear guidelines on monitoring studies for the treatment of H. pylori, showing that there is insufficient clinical and scientific evidence to delineate the cutoff points for amoxicillin, metronidazole, levofloxacin, and tetracycline in the eradication of H. pylori [48,49]. Larger studies are necessary to find the correlation of efficacy with the different levels of antibiotic susceptibility, mainly in Latin-America.…”
Section: Antibiotic Susceptibilitymentioning
confidence: 80%
“…Interestingly, the duality of resistance rates was observed in this article for amoxicillin due to discordant cutoff proposed by the literature for Latin America [45] and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) [47]. This difference demonstrated the lack of clear guidelines on monitoring studies for the treatment of H. pylori, showing that there is insufficient clinical and scientific evidence to delineate the cutoff points for amoxicillin, metronidazole, levofloxacin, and tetracycline in the eradication of H. pylori [48,49]. Larger studies are necessary to find the correlation of efficacy with the different levels of antibiotic susceptibility, mainly in Latin-America.…”
Section: Antibiotic Susceptibilitymentioning
confidence: 80%
“…In Europe, metronidazole resistance has been estimated in the range of 30–40% [ 5 , 6 ] and this prevalence of resistance in H. pylori is even higher in developing countries ranging from 40.5% to 95.4% [ 50 ]. Metronidazole has been widely prescribed for infections such as parasitic or female genital infections and could contribute to the high resistance rate found everywhere [ 51 ]. Although rifampicin is not commonly used as a first treatment option in H. pylori infection, we observed a rising rate of resistance in comparison with previous reports [ 52 , 53 , 54 ].…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, it is estimated that among antibiotics used for the treatment of H. pylori, resistance rates to amoxicillin and tetracycline are the lowest. The level of resistance to these antibiotics has been reported as very low (< 10%) or even absent in Europe [ 5 , 6 , 51 ]. In the present work, only one strain was resistant to amoxicillin ( Hp1 strain), and no resistant strains to tetracycline were detected.…”
Section: Discussionmentioning
confidence: 99%
“…The in vitro minimum inhibitory concentrations (MICs) of the five antibiotics against the H. pylori clinical isolates were defined by the points of intersection of the inhibitory zones with the strips. To determine susceptibility, we adopted the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines [ 19 ]. The MIC breakpoints for amoxicillin, clarithromycin, metronidazole, tetracycline, and levofloxacin were >0.125, >0.5, >8, >1, and >1 mg/L, respectively.…”
Section: Methodsmentioning
confidence: 99%